The objective of this study is to examine of induction success and maternal & fetal complications of Iso sorbide Mono Nitrate(IMN) on cervical ripening .The inclusion criteria: 1-single pregnancy, 2- cephalic presentation, 3- Bishop Score ≤6, 4-normal AFI>5, 5- regular FHR, 6- intact membrane, 7- gestational age ≥37 weeks. Exclusion criteria are: Uterine contraction (≥3 contraction 45’’ in 10 minutes) previous mymomectomy, history of headache, intolerance IMN, cardiopulmonary disease, vaso previa or placenta previa, cord prolepses, classic incision or previous myomectomy, irregular FHR, multiple pregnancy, macrosomia, polyhydramious, severe preeclampsia, maternal short stature. All candidates take an informed consent and assigned randomly into two groups (receiving 40 mg IMN or placebo). Outcomes are : interval between admission to Normal vaginal delivery, type of delivery(NVD-C/S), bleeding level, interval between admission and active phase, neonatal outcomes (APGAR score, NICU admission), maternal outcomes ( headache, palpitation), fetal outcome (tacysystole, hyperstimulation syndrome, hypersystole)